<- Go Home

PolyNovo Limited

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Market Cap

AUD 663.2M

Volume

2.6M

Cash and Equivalents

AUD 35.4M

EBITDA

AUD 15.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

AUD 129.3M

Profit Margin

86.28%

52 Week High

AUD 1.66

52 Week Low

AUD 0.81

Dividend

N/A

Price / Book Value

7.31

Price / Earnings

91.43

Price / Tangible Book Value

7.35

Enterprise Value

AUD 645.3M

Enterprise Value / EBITDA

38.47

Operating Income

AUD 13.3M

Return on Equity

8.44%

Return on Assets

6.42

Cash and Short Term Investments

AUD 35.5M

Debt

AUD 17.6M

Equity

AUD 90.7M

Revenue

AUD 149.8M

Unlevered FCF

-AUD 1.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches